{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:06Z","timestamp":1790638626369,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Huntington\u2019s disease (HD) is an autosomal dominant disorder caused by an expanded CAG repeat (greater than 38) on the short arm of chromosome 4, resulting in loss and dysfunction of neurons in the neostriatum and cortex, leading to cognitive decline, motor dysfunction, and death, typically occurring 15 to 20\u00a0years after the onset of motor symptoms. Although an effective treatment for HD has remained elusive, current studies using transplants of bone-marrow-derived mesenchymal stem cells provides considerable promise. This study further investigates the efficacy of these transplants with a focus on comparing how passage number of these cells may affect subsequent efficacy following transplantation.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>In this study, mesenchymal stem cells isolated from the bone-marrow of mice (BM MSCs), were labeled with Hoechst after low (3 to 8) or high (40 to 50) numbers of passages and then transplanted intrastriatally into 5-week-old R6\/2 mice, which carries the N-terminal fragment of the human HD gene (145 to 155 repeats) and rapidly develops symptoms analogous to the human form of the disease.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>It was observed that the transplanted cells survived and the R6\/2 mice displayed significant behavioral and morphological sparing compared to untreated R6\/2 mice, with R6\/2 mice receiving high passage BM MSCs displaying fewer deficits than those receiving low-passage BM MSCs. These beneficial effects are likely due to trophic support, as an increase in brain derived neurotrophic factor mRNA expression was observed in the striatum following transplantation of BM MSCs.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>The results from this study demonstrate that BM MSCs hold significant therapeutic value for HD, and that the amount of time the cells are exposed to <jats:italic>in vitro<\/jats:italic> culture conditions can alter their efficacy.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/scrt545","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T04:22:49Z","timestamp":1434601369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Reductions in behavioral deficits and neuropathology in the R6\/2 mouse model of Huntington\u2019s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number"],"prefix":"10.1186","volume":"6","author":[{"given":"Julien","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra K","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Bombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Clerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M","family":"Bavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Lowrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Lescaudron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,19]]},"reference":[{"key":"426_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada S\u00e1nchez","year":"2008","unstructured":"Estrada S\u00e1nchez AM, Mej\u00eda-Toiber J, Massieu L: Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease.\n                           Arch Med Res 2008, 39:265\u201376. 10.1016\/j.arcmed.2007.11.011","journal-title":"Arch Med Res"},{"key":"426_CR2","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH: Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease.\n                           J Neurosci 2009, 29:13589\u2013602. 10.1523\/JNEUROSCI.4286-09.2009","journal-title":"J Neurosci"},{"key":"426_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al.: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.\n                           Cell 1996, 87:493\u2013506. 10.1016\/S0092-8674(00)81369-0","journal-title":"Cell"},{"key":"426_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","volume":"30","author":"Z DeMarch","year":"2008","unstructured":"DeMarch Z, Giamp\u00e0 C, Patassini S, Bernardi G, Fusco FR: Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease.\n                           Neurobiol Dis 2008, 30:375\u201387. 10.1016\/j.nbd.2008.02.010","journal-title":"Neurobiol Dis"},{"key":"426_CR5","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, et al.: Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation.\n                           J Neurosci 2000, 20:5115\u201323.","journal-title":"J Neurosci"},{"key":"426_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al.: Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease.\n                           Science 2001, 293:493\u20138. 10.1126\/science.1059581","journal-title":"Science"},{"key":"426_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, et al.: Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery.\n                           Pharmacol Res 2005, 52:133\u20139. 10.1016\/j.phrs.2005.01.001","journal-title":"Pharmacol Res"},{"key":"426_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, et al.: Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease.\n                           Behav Brain Res 2010, 214:193\u2013200. 10.1016\/j.bbr.2010.05.023","journal-title":"Behav Brain Res"},{"key":"426_CR9","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","volume":"102","author":"K Jin","year":"2005","unstructured":"Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J, Crippen D, et al.: FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington\u2019s disease.\n                           Proc Natl Acad Sci U S A 2005, 102:18189\u201394. 10.1073\/pnas.0506375102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","volume":"217","author":"J Rossignol","year":"2011","unstructured":"Rossignol J, Boyer C, L\u00e9v\u00e8que X, Fink KD, Thinard R, Blanchard F, et al.: Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes.\n                           Behav Brain Res 2011, 217:369\u201378. 10.1016\/j.bbr.2010.11.006","journal-title":"Behav Brain Res"},{"key":"426_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","volume":"5","author":"A-C Bachoud-L\u00e9vi","year":"2006","unstructured":"Bachoud-L\u00e9vi A-C, Gaura V, Brugi\u00e8res P, Lefaucheur J-P, Boiss\u00e9 M-F, Maison P, et al.: Effect of fetal neural transplants in patients with Huntington\u2019s disease 6\u00a0years after surgery: a long-term follow-up study.\n                           Lancet Neurol 2006, 5:303\u20139. 10.1016\/S1474-4422(06)70381-7","journal-title":"Lancet Neurol"},{"key":"426_CR12","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1073\/pnas.0904239106","volume":"106","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR, et al.: Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration.\n                           Proc Natl Acad Sci U S A 2009, 106:12483\u20138. 10.1073\/pnas.0904239106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR13","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","volume":"68","author":"CD Keene","year":"2007","unstructured":"Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, et al.: Neural transplantation in Huntington disease: long-term grafts in two patients.\n                           Neurology 2007, 68:2093\u20138. 10.1212\/01.wnl.0000264504.14301.f5","journal-title":"Neurology"},{"key":"426_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","volume":"117","author":"CD Keene","year":"2009","unstructured":"Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, Hevner RF, et al.: A patient with Huntington\u2019s disease and long-surviving fetal neural transplants that developed mass lesions.\n                           Acta Neuropathol 2009, 117:329\u201338. 10.1007\/s00401-008-0465-0","journal-title":"Acta Neuropathol"},{"key":"426_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0166-2236(00)01680-5","volume":"23","author":"C Svendsen","year":"2000","unstructured":"Svendsen C: Adult versus embryonic stem cells: which is the way forward?\n                           Trends Neurosci 2000, 23:450.","journal-title":"Trends Neurosci"},{"key":"426_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al.: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.\n                           Cytotherapy 2006, 8:315\u20137. 10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"426_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/00207450390207759","volume":"113","author":"L Lescaudron","year":"2003","unstructured":"Lescaudron L, Unni D, Dunbar GL: Autologous adult bone marrow stem cell transplantation in an animal model of Huntington\u2019s disease: behavioral and morphological outcomes.\n                           Int J Neurosci 2003, 113:945\u201356. 10.1080\/00207450390207759","journal-title":"Int J Neurosci"},{"key":"426_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1534582306289367","volume":"5","author":"GL Dunbar","year":"2006","unstructured":"Dunbar GL, Sandstrom MI, Rossignol J, Lescaudron L: Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington\u2019s disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.\n                           Behav Cogn Neurosci Rev 2006, 5:63\u201379. 10.1177\/1534582306289367","journal-title":"Behav Cogn Neurosci Rev"},{"key":"426_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/scd.2010.0266","volume":"20","author":"N Ahmadbeigi","year":"2011","unstructured":"Ahmadbeigi N, Soleimani M, Gheisari Y, Vasei M, Amanpour S, Bagherizadeh I, et al.: Dormant phase and multinuclear cells: two key phenomena in early culture of murine bone marrow mesenchymal stem cells.\n                           Stem Cells Dev 2011, 20:1337\u201347. 10.1089\/scd.2010.0266","journal-title":"Stem Cells Dev"},{"key":"426_CR20","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1111\/j.1582-4934.2008.00657.x","volume":"13","author":"J Rossignol","year":"2009","unstructured":"Rossignol J, Boyer C, Thinard R, Remy S, Dugast A-S, Dubayle D, et al.: Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation.\n                           J Cell Mol Med 2009, 13:2547\u201358. 10.1111\/j.1582-4934.2008.00657.x","journal-title":"J Cell Mol Med"},{"key":"426_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-61779-815-3_10","volume":"879","author":"L Lescaudron","year":"2012","unstructured":"Lescaudron L, Boyer C, Bonnamain V, Fink KD, L\u00e9v\u00eaque X, Rossignol J, et al.: Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases.\n                           Methods Mol Biol 2012, 879:147\u201364. 10.1007\/978-1-61779-815-3_10","journal-title":"Methods Mol Biol"},{"key":"426_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","volume":"12","author":"P Samadi","year":"2013","unstructured":"Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann J-C, et al.: Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington\u2019s disease.\n                           Genes Brain Behav 2013, 12:108\u201324. 10.1111\/j.1601-183X.2012.00858.x","journal-title":"Genes Brain Behav"},{"key":"426_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/scrt341","volume":"4","author":"KD Fink","year":"2013","unstructured":"Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, et al.: Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6\/2 mice: behavioral and neuropathological analysis.\n                           Stem Cell Res Ther 2013, 4:130. 10.1186\/scrt341","journal-title":"Stem Cell Res Ther"},{"key":"426_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ: Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator.\n                           Anat Rec 1991, 231:482\u201397. 10.1002\/ar.1092310411","journal-title":"Anat Rec"},{"key":"426_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.brainresrev.2011.02.005","volume":"67","author":"R Lalonde","year":"2011","unstructured":"Lalonde R, Strazielle C: Brain regions and genes affecting limb-clasping responses.\n                           Brain Res Rev 2011, 67:252\u20139. 10.1016\/j.brainresrev.2011.02.005","journal-title":"Brain Res Rev"},{"key":"426_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nlm.2006.09.008","volume":"87","author":"O Eschenko","year":"2007","unstructured":"Eschenko O, Mizumori SJY: Memory influences on hippocampal and striatal neural codes: effects of a shift between task rules.\n                           Neurobiol Learn Mem 2007, 87:495\u2013509. 10.1016\/j.nlm.2006.09.008","journal-title":"Neurobiol Learn Mem"},{"key":"426_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1179\/174313209X409025","volume":"32","author":"M-A Edalatmanesh","year":"2010","unstructured":"Edalatmanesh M-A, Matin MM, Neshati Z, Bahrami A-R, Kheirabadi M: Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum.\n                           Neurol Res 2010, 32:166\u201372. 10.1179\/174313209X409025","journal-title":"Neurol Res"},{"key":"426_CR28","doi-asserted-by":"publisher","first-page":"e59438","DOI":"10.1371\/journal.pone.0059438","volume":"8","author":"W Im","year":"2013","unstructured":"Im W, Ban J, Lim J, Lee M, Lee S-T, Chu K, et al.: Extracts of adipose derived stem cells slows progression in the R6\/2 model of Huntington\u2019s disease.\n                           PLoS One 2013, 8:e59438. 10.1371\/journal.pone.0059438","journal-title":"PLoS One"},{"key":"426_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","volume":"21","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Hunt MJ, Hodges AK, Lewis PD, Redfern AJ, Dunnett SB, et al.: A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington\u2019s disease.\n                           Eur J Neurosci 2005, 21:855\u201370. 10.1111\/j.1460-9568.2005.03895.x","journal-title":"Eur J Neurosci"},{"key":"426_CR30","doi-asserted-by":"publisher","first-page":"e9347","DOI":"10.1371\/journal.pone.0009347","volume":"5","author":"BR Snyder","year":"2010","unstructured":"Snyder BR, Chiu AM, Prockop DJ, Chan AWS: Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington\u2019s disease.\n                           PLoS One 2010, 5:e9347. 10.1371\/journal.pone.0009347","journal-title":"PLoS One"},{"key":"426_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1179\/174313208X327955","volume":"30","author":"EM Amin","year":"2008","unstructured":"Amin EM, Reza BA, Morteza BR, Maryam MM, Ali M, Zeinab N: Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration.\n                           Neurol Res 2008, 30:1086\u201390. 10.1179\/174313208X327955","journal-title":"Neurol Res"},{"key":"426_CR32","doi-asserted-by":"publisher","first-page":"e22924","DOI":"10.1371\/journal.pone.0022924","volume":"6","author":"Y-T Lin","year":"2011","unstructured":"Lin Y-T, Chern Y, Shen C-KJ, Wen H-L, Chang Y-C, Li H, et al.: Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington\u2019s disease mouse models.\n                           PLoS One 2011, 6:e22924. 10.1371\/journal.pone.0022924","journal-title":"PLoS One"},{"key":"426_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.mcn.2007.11.001","volume":"37","author":"K Bantubungi","year":"2008","unstructured":"Bantubungi K, Blum D, Cuvelier L, Wislet-Gendebien S, Rogister B, Brouillet E, et al.: Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington\u2019s disease.\n                           Mol Cell Neurosci 2008, 37:454\u201370. 10.1016\/j.mcn.2007.11.001","journal-title":"Mol Cell Neurosci"},{"key":"426_CR34","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1634\/stemcells.2008-0240","volume":"26","author":"O Sadan","year":"2008","unstructured":"Sadan O, Shemesh N, Barzilay R, Bahat-Stromza M, Melamed E, Cohen Y, et al.: Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging.\n                           Stem Cells 2008, 26:2542\u201351. 10.1634\/stemcells.2008-0240","journal-title":"Stem Cells"},{"key":"426_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","volume":"24","author":"M Miura","year":"2006","unstructured":"Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, et al.: Accumulated Chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.\n                           Stem Cells 2006, 24:1095\u2013103. 10.1634\/stemcells.2005-0403","journal-title":"Stem Cells"},{"key":"426_CR36","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1158\/0008-5472.CAN-06-2146","volume":"66","author":"YF Zhou","year":"2006","unstructured":"Zhou YF, Bosch-Marce M, Okuyama H, Krishnamachary B, Kimura H, Zhang L, et al.: Spontaneous transformation of cultured mouse bone marrow-derived stromal cells.\n                           Cancer Res 2006, 66:10849\u201354. 10.1158\/0008-5472.CAN-06-2146","journal-title":"Cancer Res"},{"key":"426_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ajmg.b.30501","volume":"144B","author":"A Ciammola","year":"2007","unstructured":"Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, et al.: Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients.\n                           Am J Med Genet B Neuropsychiatr Genet 2007, 144B:574\u20137. 10.1002\/ajmg.b.30501","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"426_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","volume":"39","author":"P Conforti","year":"2008","unstructured":"Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, et al.: Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington\u2019s disease: restoration by the neuroprotective compound CEP-1347.\n                           Mol Cell Neurosci 2008, 39:1\u20137. 10.1016\/j.mcn.2008.04.012","journal-title":"Mol Cell Neurosci"},{"key":"426_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1179\/016164110X12816242542571","volume":"33","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Lv H, Huang S, Tan H, Zhang Y, Li H: Bone marrow mesenchymal stem cells can improve the motor function of a Huntington\u2019s disease rat model.\n                           Neurol Res 2011, 33:331\u20137. 10.1179\/016164110X12816242542571","journal-title":"Neurol Res"},{"key":"426_CR40","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al.: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.\n                           Circulation 2004, 109:1292\u20138. 10.1161\/01.CIR.0000121425.42966.F1","journal-title":"Circulation"},{"key":"426_CR41","doi-asserted-by":"publisher","first-page":"R880","DOI":"10.1152\/ajpregu.00280.2006","volume":"291","author":"M Wang","year":"2006","unstructured":"Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism.\n                           Am J Physiol Regul Integr Comp Physiol 2006, 291:R880\u20134. 10.1152\/ajpregu.00280.2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"426_CR42","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.0508875103","volume":"103","author":"JL McBride","year":"2006","unstructured":"McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, et al.: Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington\u2019s disease.\n                           Proc Natl Acad Sci U S A 2006, 103:9345\u201350. 10.1073\/pnas.0508875103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR43","volume-title":"J Tissue Eng Regen Med","author":"A Bertolo","year":"2013","unstructured":"Bertolo A, Mehr M, Janner-Jametti T, Graumann U, Aebli N, Baur M, et al.: An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells.\n                           J Tissue Eng Regen Med 2013. http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/term.1734\/abstract"},{"key":"426_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2184.2012.00836.x","volume":"45","author":"J Chang","year":"2012","unstructured":"Chang J, Lei H, Liu Q, Qin S, Ma K, Luo S, et al.: Optimization of culture of mesenchymal stem cells: a comparison of conventional plate and microcarrier cultures.\n                           Cell Prolif 2012, 45:430\u20137. 10.1111\/j.1365-2184.2012.00836.x","journal-title":"Cell Prolif"},{"key":"426_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5966\/sctm.2011-0011","volume":"1","author":"DP Lennon","year":"2012","unstructured":"Lennon DP, Schluchter MD, Caplan AI: The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells.\n                           Stem Cells Transl Med 2012, 1:279\u201388. 10.5966\/sctm.2011-0011","journal-title":"Stem Cells Transl Med"},{"key":"426_CR46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3892\/mmr.2012.1039","volume":"6","author":"X-Y Li","year":"2012","unstructured":"Li X-Y, Ding J, Zheng Z-H, Li X-Y, Wu Z-B, Zhu P: Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells.\n                           Mol Med Rep 2012, 6:1183\u20139.","journal-title":"Mol Med Rep"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/scrt545\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:26:31Z","timestamp":1728923191000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/scrt545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1186\/scrt545","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,19]]},"assertion":[{"value":"20 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}